EZH2 and Miyoshi myopathy: Among these 97 patients, gene expression profiling data of purified MM cells were available for 51 patients and we identified that high EZH2 expression is associated with a significant shorter event free survival after treatment by anti-CD38 MoAb (p = 0.02; Supplementary Fig. S1D).